Learn More
Medchemexpress LLC Entasobulin | 501921-61-5 | 98.5% | 439.89 | 50 MG

Supplier: Medchemexpress LLC HY1677750MG
Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity. It is an indolizine-glyoxylamide based small molecule that demonstrates substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes.
- Inhibits β-tubulin polymerization
- Shows potential anticancer activity
- Demonstrates substantial in vitro anti-proliferative activities against cancer cell lines
- Effective against multidrug resistance (MDR) phenotypes
- For research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.